Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation

Bone Marrow Transplantation volume 35, pages 997–1001 (2005)Cite this article

Summary:

Autologous stem cell transplantation has augmented treatment successes. However, high-dose chemotherapy is still accompanied by dose-limiting toxicities, for example, severe mucositis. Mucosal lesions serve as portals of entry for infections. In order to reduce the oral microbial burden, we prospectively evaluated the microbiological impact of a complex regimen of mouth rinses consisting of concomitantly applied polyene antifungals, povidone-iodine, chlorhexidine, sage tea, and prophylactic ciprofloxacin and fluconazole. A total of 15 patients were enrolled into this longitudinal evaluation. Colony-forming units (CFU) were quantitated from saliva, buccal and palatinal swabs during high-dose chemotherapy and autologous stem cell transplantation. The number of CFU did not show any significant changes after initiation of the mouth rinses and the prophylactic antibiotics. The median CFU count was 268 × 106/ml saliva before chemotherapy and decreased after initiation of intravenous antibiotics only. Neither prophylactic nor therapeutic antifungals significantly reduced the number of cultures positive for yeasts. Since 90% of our patients had febrile neutropenia at some time point during the observation period, the approach evaluated cannot be recommended as prophylaxis of febrile neutropenia as such.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Farquhar C, Basser R, Hetrick S et al. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 2003; 1: CD003142.

    Google Scholar 

  2. Imrie K, Esmail R, Meyer RM . The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative. Ann Intern Med 2002; 136: 619–629.

    Article  PubMed  Google Scholar 

  3. Ferme C, Mounier N, Divine M et al. Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. J Clin Oncol 2002; 20: 467–475.

    CAS  PubMed  Google Scholar 

  4. Brice P, Simon D, Bouabdallah R et al. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Ann Oncol 2000; 11: 1585–1590.

    Article  CAS  PubMed  Google Scholar 

  5. Sweetenham JW, Santini G, Qian W et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927–2936.

    Article  CAS  PubMed  Google Scholar 

  6. Copelan EA, Penza SL, Pohlman B et al. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2000; 25: 1243–1248.

    Article  CAS  PubMed  Google Scholar 

  7. Meloni G, Capria S, Trasarti S et al. High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study. Bone Marrow Transplant 2000; 26: 1045–1049.

    Article  CAS  PubMed  Google Scholar 

  8. NCI Common Toxicity Criteria 2.0: NHI, DHHS; 1998.

  9. Moreau P, Facon T, Attal M et al. Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 2002; 99: 731–735.

    Article  CAS  PubMed  Google Scholar 

  10. Stiff P . Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 2001; 27 (Suppl. 2): S3–S11.

    Article  PubMed  Google Scholar 

  11. Cornely OA, Schirmacher P . Clinical picture: bacterial translocation in neutropenic sepsis. Lancet 2001; 358: 1842.

    Article  CAS  PubMed  Google Scholar 

  12. Raber-Durlacher JE . Current practices for management of oral mucositis in cancer patients. Support Care Cancer 1999; 7: 71–74.

    Article  CAS  PubMed  Google Scholar 

  13. Sonis ST . Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998; 34: 39–43.

    Article  CAS  PubMed  Google Scholar 

  14. Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234–240.

    Article  CAS  PubMed  Google Scholar 

  15. Kern WV, Beyer J, Bohme A et al. Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on infections in hematology and oncology. Dtsch Med Wochenschr 2000; 125: 1582–1588.

    Article  CAS  PubMed  Google Scholar 

  16. Yildirim A, Mavi A, Oktay M et al. Comparison of antioxidant and antimicrobial activities of tilia (Tilia argentea Desf ex DC), sage (Salvia triloba l.) and black tea (Camellia sinensis) extracts. J Agric Food Chem 2000; 48: 5030–5034.

    Article  CAS  PubMed  Google Scholar 

  17. Donnelly JP, Bellm LA, Epstein JB et al. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003; 3: 405–412.

    Article  PubMed  Google Scholar 

  18. Eilers J, Berger AM, Petersen MC . Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 1988; 15: 325–330.

    CAS  PubMed  Google Scholar 

  19. Epstein JB, Vickars L, Spinelli J, Reece D . Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1992; 73: 682–689.

    Article  CAS  PubMed  Google Scholar 

  20. Ferretti GA, Raybould TP, Brown AT et al. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol 1990; 69: 331–338.

    Article  CAS  PubMed  Google Scholar 

  21. Rutkauskas JS, Davis JW . Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol 1993; 76: 441–448.

    Article  CAS  PubMed  Google Scholar 

  22. Brown AT, Sims RE, Raybould TP et al. Oral gram-negative bacilli in bone marrow transplant patients given chlorhexidine rinses. J Dent Res 1989; 68: 1199–1204.

    Article  CAS  PubMed  Google Scholar 

  23. Cheng KK, Molassiotis A, Chang AM et al. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 2001; 37: 2056–2063.

    Article  CAS  PubMed  Google Scholar 

  24. Dodd MJ, Larson PJ, Dibble SL et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 1996; 23: 921–927.

    CAS  PubMed  Google Scholar 

  25. Adamietz IA, Rahn R, Bottcher HD et al. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy. Support Care Cancer 1998; 6: 373–377.

    Article  CAS  PubMed  Google Scholar 

  26. Ferretti GA, Ash RC, Brown AT et al. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant 1988; 3: 483–493.

    CAS  PubMed  Google Scholar 

  27. Dodd MJ, Dibble SL, Miaskowski C et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 39–47.

    Article  CAS  PubMed  Google Scholar 

  28. Worthington HV, Clarkson JE . Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy: cochrane systematic review. J Dent Educ 2002; 66: 903–911.

    CAS  PubMed  Google Scholar 

  29. Wijers OB, Levendag PC, Harms ER et al. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 2001; 50: 343–352.

    Article  CAS  PubMed  Google Scholar 

  30. Bondi E, Baroni C, Prete A et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. Oral Oncol 1997; 33: 322–326.

    Article  CAS  PubMed  Google Scholar 

  31. Okuno SH, Foote RL, Loprinzi CL et al. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 1997; 79: 2193–2199.

    Article  CAS  PubMed  Google Scholar 

  32. Spijkervet FK, Van Saene HK, Van Saene JJ et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991; 46: 167–173.

    Article  CAS  PubMed  Google Scholar 

  33. Rahn R, Adamietz IA, Boettcher HD et al. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 1997; 195 (Suppl. 2): 57–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universität Koeln, Klinik I für Innere Medizin, Koeln, Germany

    H Lövenich, H Schütt-Gerowitt, C Keulertz, D Waldschmidt, U Bethe, D Söhngen & O A Cornely

Authors
  1. H Lövenich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Schütt-Gerowitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Keulertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Waldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U Bethe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Söhngen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O A Cornely
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O A Cornely.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lövenich, H., Schütt-Gerowitt, H., Keulertz, C. et al. Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation. Bone Marrow Transplant 35, 997–1001 (2005). https://doi.org/10.1038/sj.bmt.1704933

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704933

Keywords

This article is cited by

Search

Advanced search

Quick links